0.3151
Precedente Chiudi:
$0.3326
Aprire:
$0.329
Volume 24 ore:
876.82K
Relative Volume:
0.15
Capitalizzazione di mercato:
$17.38M
Reddito:
-
Utile/perdita netta:
$-27.04M
Rapporto P/E:
-0.1596
EPS:
-1.9743
Flusso di cassa netto:
$-17.53M
1 W Prestazione:
+14.58%
1M Prestazione:
-23.89%
6M Prestazione:
-86.82%
1 anno Prestazione:
-93.52%
Medicus Pharma Ltd Stock (MDCX) Company Profile
Nome
Medicus Pharma Ltd
Settore
Industria
Telefono
610-540-7515
Indirizzo
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX vs LLY, JNJ, ABBV, AZN, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MDCX
Medicus Pharma Ltd
|
0.3151 | 18.35M | 0 | -27.04M | -17.53M | -1.9743 |
|
LLY
Lilly Eli Co
|
989.87 | 862.31B | 72.25B | 25.28B | 10.37B | 27.78 |
|
JNJ
Johnson Johnson
|
224.26 | 533.03B | 96.36B | 21.04B | 17.80B | 8.6488 |
|
ABBV
Abbvie Inc
|
207.86 | 358.27B | 62.82B | 3.60B | 19.98B | 2.0274 |
|
AZN
Astrazeneca Plc
|
184.54 | 282.04B | 60.48B | 10.40B | 8.05B | 3.3297 |
|
NVS
Novartis Ag Adr
|
148.16 | 277.11B | 54.66B | 13.58B | 16.05B | 7.0171 |
Medicus Pharma Ltd Borsa (MDCX) Ultime notizie
symbol__ Stock Quote Price and Forecast - CNN
New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN) - Moomoo
Medicus Pharma Ltd expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Maxim Group Maintains Medicus Pharma(MDCX.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Medicus Pharma Reports Expanded Phase 2 Skin Cancer Trial Data - MyChesCo
MDCX Stock Price, Quote & Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
EXCLUSIVE: Medicus Sees Strongest Efficacy At Higher Dose In Skin Cancer Study - Sahm
Market movers: Uber, Super Micro Computer, Medicus Pharma, Arizona Gold & Silver, Hut 8... - Proactive financial news
Medicus Pharma reports strong Phase 2 dose response in skin cancer study - Proactive financial news
Medicus Pharma reports dose response data from skin cancer study By Investing.com - Investing.com India
Medicus Pharma reports dose response data from skin cancer study - Investing.com UK
Medicus Pharma highlights positive dose-response in updated skin cancer trial results - Yahoo Finance
$Medicus Pharma (MDCX.US)$ - Moomoo
Skin cancer study points to higher-dose winner with 55% response - Stock Titan
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response - ChartMill
Medicus Pharma (MDCX) 10K Form and Latest SEC Filings 2026 - MarketBeat
Medicus Pharma Meets Lawmakers to Advance SkinJect Program - MyChesCo
Medicus reports Phase 2 basal cell carcinoma trial results By Investing.com - Investing.com India
MDCX Forecast, Price Target & Analyst Ratings | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
MDCX SEC FilingsMedicus Pharma Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Medicus Pharma on Bloomberg World - Public Opinion
Medicus Pharma 2025 Executive Compensation, Board Governance, and Equity Incentive Plan Overview - Minichart
Medicus Pharma (Nasdaq: MDCX) details board structure and leadership pay - Stock Titan
Exclusive: Medicus Pharma refines trial design to cut costs, accelerate development for enlarged prostate patients - MSN
10-K/A: Annual report (Amendment) - Moomoo
MDCX Technical Analysis | Trend, Signals & Chart Patterns | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill
MDCXW Price History for Medicus Pharma Ltd WT Stock - Barchart.com
Medicus Pharma lobbies Congress on SkinJect regulatory pathway for rare Gorlin syndrome - Yahoo! Finance Canada
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill - The Manila Times
Medicus Pharma to acquire Antev for $75M in share exchange transaction - MSN
Medicus Pharma prices $7 million share offering - MSN
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global - ACCESS Newswire
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ - marketscreener.com
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines - TipRanks
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Wisconsin Farmer
Medicus Pharma (NASDAQ: MDCX) ups ATM to $50M; Nasdaq bid‑price notice - Stock Titan
Medicus Pharma receives Nasdaq notice for minimum bid price non-compliance - Investing.com UK
Medicus Pharma Expands ATM Equity Program for Funding - TipRanks
Medicus Pharma Upsizes ATM Program to $50 Million With Maxim Group and Yorkville Securities - TradingView
Nasdaq warns Medicus Pharma (NASDAQ: MDCX) on $1 bid price rule - Stock Titan
Medicus Pharma advances Skinject in rare disease – ICYMI - Proactive financial news
Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):